Ethanolic extract of Actaea racemosa (black cohosh) potentiates bone nodule formation in MC3T3-E1 preosteoblast cells

Bone

Volumn 43, Issue 3, 2008, Pages 567-573

  Chan, B Y ^a   Lau, K S ^a   Jiang, B ^b,c   Kennelly, E J ^b   Kronenberg, F ^c   Kung, A W C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c College of Physicians and Surgeons ^*  (United States)

Author keywords

Actaea racemosa; Black cohosh; Cimicifuga racemosa; Estrogen receptor; ICI 182 780; MC3T3 E1; Osteoblast

Indexed keywords

ALCOHOL; CIMICIFUGA RACEMOSA EXTRACT; ESTROGEN RECEPTOR; FULVESTRANT; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; GENE INDUCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; POLYMERASE CHAIN REACTION;

ANIMALS; BONE AND BONES; CELL PROLIFERATION; CIMICIFUGA; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN ANTAGONISTS; ETHANOL; MICE; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PLANT EXTRACTS; RECEPTORS, ANDROGEN;

EID: 49149112633     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.04.018     Document Type: Article

References (44)

1. Anderson J., and Garner S. Phytoestrogens and bone. Bailieres Clin Endocrinol Metab 12 (1998) 543-557
2. Bai W., Henneicke-von Zepelin H., Wang S., Zheng S., Liu J., Zhang Z., et al. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone. Maturitas 58 (2007) 31-41
3. Braidman I., Hainey L., Batra G., Selby P., Saunders P., and Hoyland J. Localization of estrogen receptor β protein expression in adult human bone. J Bone Miner Res 16 (2001) 214-220
4. Byers B., Pavlath G., Murphy T., Karsenty G., and Garci'a A. Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfal. J Bone Miner Res 17 (2002) 1931-1944
5. Cappuzzo K., and Delafuente J. Teriparatide for severe osteoporosis. Ann Pharmacother 38 (2004) 294-302
6. Cheng M., Rawlinson S., Pitsillides A., Zaman G., Mohan S., Baylink D., et al. Human osteoblasts' proliferative responses to strain and 17beta-estradiol are mediated by the estrogen receptor and the receptor for insulin-like growth factor I. J Bone Miner Res 17 (2002) 593-602
7. Cheung W., Ng W., and Kung A. Dimethyl sulfoxide as an inducer of differentiation in preosteoblast MC3T3-E1 cells. FEBS Lett 580 (2006) 121-126
8. Deniz G., Antoine C., Liebens F., Carly B., Pastijn A., and Rozenberg S. Treatment of premature menopause in breast cancer patients. Acta Chir Belg 107 (2007) 263-266
9. Ducy P., Zhang R., Geoffroy V., Ridall A., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
10. Fitzpatrick L. Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women. Mayo Clin Proc 74 (1999) 601-607
11. Gold D., and Silverman S. Do estrogen or selective estrogen receptor modulators improve quality of life for women with postmenopausal osteoporosis?. Curr Osteoporos Rep 5 (2007) 3-7
12. Henneicke-von Zepelin H., Zepelin H., Meden H., Kostev K., Schroder-Bernhardi D., Stammwitz U., et al. Isopropanolic black cohosh extract and recurrence-free survival after breast cancer. Int J Clin Pharmacol Ther 45 (2007) 143-154
13. Hirschberg A., Edlund M., Svane G., Azavedo E., Skoog L., and von Schoultz B. An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women. Menopause 14 (2007) 89-96
14. Hofbauer L., Khosla S., Dunstan C., Lacey D., Spelsberg T., and Riggs B. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140 (1999) 4367-4370
15. Hostanska K., Nisslein T., Freudenstein J., Reichling J., and Saller R. Evaluation of cell death caused by triterpene glycosides and phenolic substances from Cimicifuga racemosa extract in human MCF-7 breast cancer cells. Biol Pharm Bull 27 (2007) 1970-1975
16. Hostanska K., Nisslein T., Freudenstein J., Reichling J., and Saller R. Inhibitory effect of an isopropanolic extract of black cohosh on the invasiveness of MDA-mB 231 human breast cancer cells. In Vivo 21 (2007) 349-355
17. Jarry H., Stromeier S., Wuttke W., and Nahrstedt A. Petasiphenone, a phenol isolated from Cimicifuga racemosa, in vitro inhibits proliferation of the human prostate cancer cell line LNCaP. Planta Med 73 (2007) 184-187
18. Kanno S., Hirano S., and Kayama F. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells. Toxicology 196 (2004) 137-145
19. Kung A. Management of osteoporosis in Hong Kong. Clin Calcium 14 (2004) 108-111
20. Kung A., Chao H., Huang K., Need A., Taechakraichana N., Loh F., et al. Efficacy and safety of raloxifene 60 milligrams/day in postmenopausal Asian women. J Clin Endocrinol Metab 88 (2003) 3130-3136
21. Lai B., Cheung C., Luk K., and Kung A. Estrogen receptor alpha CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women. Osteoporos Int 19 (2007) 571-579
22. Lee M., Kim Y., Yoon W., Kim J., Kim B., Hwang Y., et al. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem 280 (2005) 35579-35587
23. Liske E. Therapeutic efficacy and safety of Cimicifuga racemosa for gynaecological disorders. Adv Ther 15 (1998) 45-53
24. Lupu R., Mehmi I., Atlas E., Tsai M., Pisha E., Oketch-Rabah H., et al. Black cohosh, a menopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth. Int J Oncol 23 (2003) 1407-1412
25. Nappi R., Malavasi B., Brundu B., and Facchinetti F. Efficiacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol 20 (2005) 30-35
26. Nisslein T., and Freudenstein J. Effects of an isopropanolic extract of Cimicifuga racemosa on urinary crosslinks and other parameters of bone quality in an ovariectomized rat model of osteoporosis. J Bone Miner Metab 21 (2003) 370-376
27. Osmers R., Friede M., Liske E., Schnitker J., Freudenstein J., and Henneicke-von Zepelin H. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 105 (2005) 1074-1083
28. Oursler M., Landers J., Riggs B., and Spelsberg T. Oestrogen effects on osteoblasts and osteoclasts. Ann Med 25 (1993) 361-371
29. Qiu S., Dan C., Ding L., Peng S., Chen S., Farnsworth N., et al. A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFalpha signaling pathways. Chem Biol 14 (2007) 890-899
30. Raus K., Brucker C., Gorkow C., and Wuttke W. First-time proof of endometrial safety of the special black cohosh extract (Actea or Cimicifuga racemosa extract) CR BNO 1055. Menopause 13 (2006) 678-691
31. Rice S., and Whitehead S. Phytoestrogens and breast cancer-promoters or protectors?. Endocr Relat Cancer 13 (2006) 995-1015
32. Seidlova-Wuttke D., Hesse O., Jarry H., Christoffel V., Spengler B., Becker T., et al. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta. Eur J Endocrinol 149 (2003) 351-362
33. Seidlova-Wuttke D., Jarry H., Pitzel L., and Wuttke W. Effects of estradiol-17β, testosterone and a black cohosh preparation on bone and prostate in orchidectomized rats. Maturitas 51 (2005) 177-186
34. Seidlova-Wuttke D., Sturmer K., Sturmer E., Sehmisch S., and Wuttke W. Contrasting effects of estradiol, testosterone and of a black cohosh extract on density, mechanical properties and expression of several genes in the metaphysis of the tibia and on fat tissue of orchidectomized rats. Maturitas 55S (2006) S64-S74
35. Seidlova-Wuttke D., Thelen P., and Wuttke W. Inhibitory effects of a black cohosh (Cimicifuga racemosa) extract on prostate cancer. Planta Med 72 (2006) 521-526
36. Shi Y., Worton L., Esteban L., Baldock P., Fong C., Eisman J., et al. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation. Bone 41 (2007) 87-96
37. Simonet W., Lacey D., Dunstan C., Kelley M., Chang M., Luthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
38. Uebelhack R., Blohmer J., Graubaum H., Busch R., Grunwald J., and Wernecke K. Black cohosh and St. John's wort for climacteric complaints. Obstet Gynecol 107 (2006) 247-255
39. Viereck V., Emons G., and Wuttke W. Black cohosh- just another phytoestrogen?. Trends Endocrinol Metab 16 (2005) 214-221
40. Viereck V., Grundker C., Friess S., Frosch K., Raddatz D., Schoppet M., et al. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts. J Bone Miner Res 20 (2005) 2036-2043
41. Walji R., Boon H., Guns E., Oneschuk D., and Younus J. Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients. Support Care Cancer 15 (2007) 913-921
42. Wuttke W., Seidlova-Wuttke D., and Gorkow C. The Cimicifuga racemosa preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 44 (2003) S67-S77
43. Zepelin H., Meden H., Kostev K., Schroder-Bernhardi D., Stammwitz U., and Becher H. Isopropanolic black cohosh extract and recurrence-free survival after breast cancer. Int J Clin Pharmacol Ther 45 (2007) 143-154
44. Zhao Z., Zhao M., Xiao G., and Franceschi R. Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Mol Ther 12 (2005) 247-253